Skip to main content
. 2013 Feb 1;15(4):254–263. doi: 10.1111/jch.12067

Table 2.

Demographics According to Blood Pressure Control

Blood Pressure Controlled Available, No. Blood Pressure Uncontrolled Available, No. P Value
Mean age, y 49.5 (10.5) 79 52.7 (13.2) 129 .05
Men 39.5% 81 59.5% 131 .01
White 56.8% 81 54.2% 131 .78
Smokers 55.6% 63 47.9% 96 .42
Insurance
Medicaid (includes Ingham Health Plan) 79.0% 81 71.8% 131 .26
Medicare 8.6% 81 13.0% 131 .38
No insurance 9.9% 81 14.5% 131 .40
Homeless 4.9% 81 5.3% 131 1.00
Cardiology Care 8.6% 81 16.0% 131 .15
Medical history
Diabetes mellitus 46.9% 81 64.1% 131 .02
Hypertension 71.6% 81 73.3% 131 .87
Coronary artery disease 11.1% 81 10.7% 131 1.00
Hyperlipidemia 40.7% 81 46.6% 131 .48
Myocardial infarction 9.9% 81 8.4% 131 .81
Angina 25.9% 81 26.0% 131 1.00
Peripheral vascular disease 3.7% 81 6.1% 131 .54
Cerebral vascular accident/stroke 1.2% 81 6.9% 131 .09
Congestive heart failure 11.8% 34 6.8% 74 .46
Chronic obstructive pulmonary disease 43.6% 39 35.8% 81 .43
Risk factors
Body mass index, mean 33.1 (9.9) 72 34.2 (11.1) 113 .47
Body mass index >30 54.2% 72 60.2% 113 .45
Body mass index >35 40.3% 72 34.5% 113 .44
No. of clinic visits 7.7 (4.5) 71 6.9 (4.7) 117 .92
No. of emergency department visits/hospitalizations 0.6 (1.6) 81 0.7 (1.6) 131 .52
Blood pressure medications, No. 1.5 (1.3) 81 1.8 (1.3) 131 .09
Mean hemoglobin A1c (diabetes mellitus) 8.3 (2.7) 33 7.9 (2.1) 68 .45
Mean low‐density lipoprotein 104.4 (32.1) 59 107.1 (33.3) 99 .62
Medications
β‐Blocker 34.6% 81 30.5% 131 .55
Angiotensin‐converting enzyme inhibitors or angiotensin receptor blocker 50.6% 81 63.4% 131 .09
Diuretics 28.4% 81 38.2% 131 .18
Calcium channel blocker 12.4% 81 21.4% 131 .10
Renin aldosterone inhibitors 3.7% 81 3.1% 131 1.00
Aspirin 14.8% 81 26.7% 131 .06
Statin 33.3% 81 38.2% 131 .56